GT Biopharma, Inc
Price
FilingsNewest: 8-K, Other eventsSep 25 →InsidersNo open-market buys or sales.→HoldersVanguard 0.8%Geode 0.6%Vanguard Fiduciary Trust 0.5%→Financing →PeersClosest companies: INDP, NMAD, RKTO→
From the filings
Figures
- Net income
- −$4.8Mlast 12 months
- Operating cash flow
- −$13.2Mlast 12 months
- Cash and equivalents
- $5.0Mat the last balance sheet
- Shares outstanding
- 44.7M shareson issue